Latigo Biotherapeutics prices $345.6M IPO at $18 per share

Latigo Biotherapeutics prices $345.6M IPO at $18 per share

Latigo Biotherapeutics prices $345.6M IPO at $18 per share
Semiconductor investors have been here before. After a scorching run, chip stocks have tumbled again, with memory names sliding more than 20% into bear market territory and the broader group shedding hundreds of billions in value. In the current artificial intelligence (AI) cycle, that kind of drop has repeatedly turned out to be a tech…
Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 10:00 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations and Corporate Development – Mike Switzer President and CEO – Harry Sideris Executive Vice President and CFO – Brian Savoy TAKEAWAYS Adjusted EPS — $1.43 per share compared to $1.25 per share in the…
Migrants cross border into Spain’s Ceuta, overwhelming police, Guardia Civil says
Wednesday’s trading session was one to forget for Metropolitan Bank (MCB -8.82%) investors. The New York-based lender took the wraps off its second-quarter results and, since they fell short of expectations, market players sold out of its stock. The shares closed the day down by almost 9%. Not quite good enough For the quarter, Metropolitan’s…
The author thanks the Editorial Committee of the Annual Review of Financial Economics, Rob Alessie, Guglielmo Briscese, Hanna Houdali, Tim Kaiser, Anita Mukherjee, Alessia Sconti, Andrea Sticha, Jialu Streeter, Carly Urban, and an anonymous reviewer for helpful suggestions and comments. She also thanks Audrey Brown and Lucy Chen for editorial and research support. Any errors…
Letter from the Governor